Ledger.Open graph →

SEC Form D · filed March 26, 2015

Cytocentrics, Inc

Offering

—

Sold

—

Exemption

Rule 506(b)

Industry

Biotechnology

Location

SAN ANTONIO, TX

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (3)

James R. Garvin · San Antonio, TXExec · Director William M. Giles · Dallas, TXExec · Director Catherine A. Fogliano · Southlake, TXExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗